Everpar Advisors LLC Takes $229,000 Position in Cencora, Inc. (NYSE:COR)

Everpar Advisors LLC bought a new position in shares of Cencora, Inc. (NYSE:COR) during the 4th quarter, HoldingsChannel reports. The institutional investor bought 1,021 shares of the company’s stock, valued at approximately $229,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Concord Wealth Partners bought a new stake in shares of Cencora in the third quarter worth $30,000. SYSTM Wealth Solutions LLC acquired a new position in Cencora during the 2nd quarter worth about $36,000. Ashton Thomas Securities LLC acquired a new position in Cencora during the 3rd quarter worth about $41,000. Fairscale Capital LLC acquired a new stake in shares of Cencora in the second quarter valued at about $54,000. Finally, Modus Advisors LLC bought a new position in shares of Cencora during the fourth quarter worth about $54,000. 97.52% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Cencora

In other news, Chairman Steven H. Collis sold 21,509 shares of the stock in a transaction that occurred on Tuesday, November 19th. The stock was sold at an average price of $242.16, for a total value of $5,208,619.44. Following the completion of the sale, the chairman now directly owns 306,752 shares of the company’s stock, valued at $74,283,064.32. This represents a 6.55 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Silvana Battaglia sold 1,678 shares of Cencora stock in a transaction that occurred on Friday, December 20th. The shares were sold at an average price of $228.72, for a total value of $383,792.16. Following the transaction, the executive vice president now directly owns 20,329 shares in the company, valued at approximately $4,649,648.88. The trade was a 7.62 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 94,696 shares of company stock valued at $22,862,734. 15.80% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

Several analysts recently commented on COR shares. Wells Fargo & Company reduced their target price on Cencora from $249.00 to $237.00 and set an “equal weight” rating on the stock in a report on Friday, December 13th. Barclays upped their price objective on shares of Cencora from $263.00 to $290.00 and gave the company an “overweight” rating in a research note on Thursday, November 7th. UBS Group lifted their target price on shares of Cencora from $275.00 to $285.00 and gave the stock a “buy” rating in a research note on Thursday, November 7th. Robert W. Baird upped their price target on shares of Cencora from $287.00 to $292.00 and gave the company an “outperform” rating in a research report on Thursday, November 7th. Finally, StockNews.com lowered Cencora from a “strong-buy” rating to a “buy” rating in a research report on Friday, September 20th. Two analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $275.60.

Cencora Stock Up 0.5 %

Shares of NYSE:COR opened at $242.11 on Friday. The company has a debt-to-equity ratio of 4.84, a quick ratio of 0.53 and a current ratio of 0.88. Cencora, Inc. has a 52-week low of $214.77 and a 52-week high of $253.27. The business’s 50 day simple moving average is $237.52 and its two-hundred day simple moving average is $233.85. The firm has a market cap of $46.80 billion, a P/E ratio of 32.24, a PEG ratio of 1.48 and a beta of 0.49.

Cencora Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, November 29th. Investors of record on Friday, November 15th were issued a $0.55 dividend. This is a boost from Cencora’s previous quarterly dividend of $0.51. This represents a $2.20 dividend on an annualized basis and a dividend yield of 0.91%. The ex-dividend date of this dividend was Friday, November 15th. Cencora’s dividend payout ratio (DPR) is currently 29.29%.

About Cencora

Cencora, Inc sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers.